Abstract |
A regulatory or suppressor T cell is functionally defined as a T cell that inhibits an immune response by influencing the activity of another cell type. On the other hand, Th1 cells express IFN-gamma and mediate cellular immunity. Sclareol exhibits growth inhibition and cytotoxic activity against a variety of human cancer cell lines. In the first set of experiments, Sclareol was isolated from the plant Salvia sclarea and our study assessed the immuno-therapeutic effectiveness of Sclareol by direct intra-tumoral injection. Secondly, several immunological parameters such as splenocytes proliferation, intra- tumor CD4+CD25+Foxp3+ Treg cells, IFN-gamma and IL-4 secretion and tumor size were assessed to evaluate the anti-tumoral immune response. By all means, the findings confirmed that the activity of Sclareol could reduce the tumor growth in vivo against breast cancer.
|
Authors | Shokoofe Noori, Zuhair M Hassan, Mehdi Mohammadi, Zohre Habibi, Nooshin Sohrabi, Saeed Bayanolhagh |
Journal | Cellular immunology
(Cell Immunol)
Vol. 263
Issue 2
Pg. 148-53
( 2010)
ISSN: 1090-2163 [Electronic] Netherlands |
PMID | 20409537
(Publication Type: Journal Article)
|
Copyright | Copyright (c) 2010. Published by Elsevier Inc. |
Chemical References |
- Antineoplastic Agents
- Cytokines
- Diterpenes
- Interleukin-4
- Interferon-gamma
- sclareol
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Breast Neoplasms
- Cell Proliferation
(drug effects)
- Cells, Cultured
- Cytokines
(metabolism)
- Diterpenes
(pharmacology)
- Female
- Flow Cytometry
- Injections, Intralesional
- Interferon-gamma
(metabolism)
- Interleukin-4
(metabolism)
- Magnetic Resonance Spectroscopy
- Mice
- Mice, Inbred BALB C
- Phytotherapy
- Sheep
- T-Lymphocytes, Regulatory
(drug effects, immunology)
|